Supply Chain Truce In COVID-19: Will It Carry Over When Rx Price Debate Resumes?

Manufacturers, insurers, pharmacies and PBMs are united in trying to assure ongoing access to medicines amid the COVID-19 outbreak. Will making common cause in a national emergency mean a more cooperative approach to addressing US drug pricing concerns when normalcy returns?

White Flag
Time To Put Down Their Weapons

There is nothing like a common enemy to bring feuding parties back together. 

The outbreak of COVID-19 appears to be having that effect on the key stakeholders in the prescription drug supply chain....

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access